Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, August 2005, p. 3222-3227, Vol. 49, No. 8
0066-4804/05/$08.00+0 doi:10.1128/AAC.49.8.3222-3227.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Ciprofloxacin Induction of a Susceptibility Determinant in Pseudomonas aeruginosa
Michelle D. Brazas and
Robert E. W. Hancock*
Department of Microbiology and Immunology, University of British Columbia, Vancouver, British Columbia, Canada
Received 12 February 2005/
Returned for modification 21 March 2005/
Accepted 24 April 2005
With few novel antimicrobials in development, resistance to the current selection of antibiotics increasingly encroaches on our ability to control microbial infections. One limitation in our understanding of the basis of the constraints on current therapies is our poor understanding of antibiotic interactions with bacteria on a global scale. Custom DNA microarrays were used to characterize the response of Pseudomonas aeruginosa to ciprofloxacin, a fluoroquinolone commonly used in therapy against chronic infections by this intrinsically resistant bacterium. Of the approximately 5,300 open reading frames (ORFs) on the array, 941 genes showed statistically significant (P
0.05) differential expression in response to 0.3x MIC of ciprofloxacin; 554 were promoted and 387 were repressed. Most striking among the responsive genes was the region between PA0613 and PA0648, which codes for the bacteriophage-like R2/F2 pyocins. In this region, virtually every ORF was increased by 0.3x MIC of ciprofloxacin and even more dramatically up-regulated (7- to 19-fold) following treatment with 1x MIC of ciprofloxacin. Pyocin gene expression was confirmed with lux reporter mutants and real-time PCR studies; pyocin-like particles were also present in transmission electron micrographs of supernatants from cells treated with 1x MIC of ciprofloxacin. Interestingly, mutants in this region exhibited
8-fold-increased resistance to ciprofloxacin and other fluoroquinolones, demonstrating that this region is a susceptibility determinant. Since this region is known to be variably present in the genomes of clinical isolates of P. aeruginosa (R. K. Ernst et al., Environ. Microbiol. 5:1341-1349, 2003, and M. C. Wolfgang et al., Proc. Natl. Acad. Sci. USA 100:8484-8489, 2003), these findings demonstrate that the R2/F2 pyocin region is a "loaded gun" that can mediate fluoroquinolone susceptibility in P. aeruginosa.
* Corresponding author. Mailing address: Centre for Microbial Diseases and Immunity Research, Room 232, 2259 Lower Mall Research Station, University of British Columbia, Vancouver, British Columbia, Canada, V6T 1Z4. Phone: (604) 822-2682. Fax: (604) 827-5566. E-mail:
bob{at}cmdr.ubc.ca.
Supplemental material for this article may be found at http://aac.asm.org/.
Antimicrobial Agents and Chemotherapy, August 2005, p. 3222-3227, Vol. 49, No. 8
0066-4804/05/$08.00+0 doi:10.1128/AAC.49.8.3222-3227.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Cummins, J., Reen, F. J., Baysse, C., Mooij, M. J., O'Gara, F.
(2009). Subinhibitory concentrations of the cationic antimicrobial peptide colistin induce the pseudomonas quinolone signal in Pseudomonas aeruginosa. Microbiology
155: 2826-2837
[Abstract]
[Full Text]
-
Waite, R. D., Curtis, M. A.
(2009). Pseudomonas aeruginosa PAO1 Pyocin Production Affects Population Dynamics within Mixed-Culture Biofilms. J. Bacteriol.
191: 1349-1354
[Abstract]
[Full Text]
-
Winstanley, C., Langille, M. G.I., Fothergill, J. L., Kukavica-Ibrulj, I., Paradis-Bleau, C., Sanschagrin, F., Thomson, N. R., Winsor, G. L., Quail, M. A., Lennard, N., Bignell, A., Clarke, L., Seeger, K., Saunders, D., Harris, D., Parkhill, J., Hancock, R. E.W., Brinkman, F. S.L., Levesque, R. C.
(2009). Newly introduced genomic prophage islands are critical determinants of in vivo competitiveness in the Liverpool Epidemic Strain of Pseudomonas aeruginosa. Genome Res
19: 12-23
[Abstract]
[Full Text]
-
Breidenstein, E. B. M., Khaira, B. K., Wiegand, I., Overhage, J., Hancock, R. E. W.
(2008). Complex Ciprofloxacin Resistome Revealed by Screening a Pseudomonas aeruginosa Mutant Library for Altered Susceptibility. Antimicrob. Agents Chemother.
52: 4486-4491
[Abstract]
[Full Text]
-
Skindersoe, M. E., Alhede, M., Phipps, R., Yang, L., Jensen, P. O., Rasmussen, T. B., Bjarnsholt, T., Tolker-Nielsen, T., Hoiby, N., Givskov, M.
(2008). Effects of Antibiotics on Quorum Sensing in Pseudomonas aeruginosa. Antimicrob. Agents Chemother.
52: 3648-3663
[Abstract]
[Full Text]
-
Brazas, M. D., Breidenstein, E. B. M., Overhage, J., Hancock, R. E. W.
(2007). Role of Lon, an ATP-Dependent Protease Homolog, in Resistance of Pseudomonas aeruginosa to Ciprofloxacin. Antimicrob. Agents Chemother.
51: 4276-4283
[Abstract]
[Full Text]
-
Moir, D. T., Ming Di, , Opperman, T., Schweizer, H. P., Bowlin, T. L.
(2007). A High-Throughput, Homogeneous, Bioluminescent Assay for Pseudomonas aeruginosa Gyrase Inhibitors and Other DNA-Damaging Agents. J Biomol Screen
12: 855-864
[Abstract]
-
Van La, M., Barbry, P., Raoult, D., Renesto, P.
(2007). Molecular basis of Tropheryma whipplei doxycycline susceptibility examined by transcriptional profiling. J Antimicrob Chemother
59: 370-377
[Abstract]
[Full Text]
-
Linares, J. F., Gustafsson, I., Baquero, F., Martinez, J. L.
(2006). Antibiotics as intermicrobial signaling agents instead of weapons. Proc. Natl. Acad. Sci. USA
103: 19484-19489
[Abstract]
[Full Text]
-
Sanders, L. H., Rockel, A., Lu, H., Wozniak, D. J., Sutton, M. D.
(2006). Role of Pseudomonas aeruginosa dinB-Encoded DNA Polymerase IV in Mutagenesis. J. Bacteriol.
188: 8573-8585
[Abstract]
[Full Text]
-
Cirz, R. T., O'Neill, B. M., Hammond, J. A., Head, S. R., Romesberg, F. E.
(2006). Defining the Pseudomonas aeruginosa SOS Response and Its Role in the Global Response to the Antibiotic Ciprofloxacin.. J. Bacteriol.
188: 7101-7110
[Abstract]
[Full Text]
-
Campos, M. A., Morey, P., Bengoechea, J. A.
(2006). Quinolones sensitize gram-negative bacteria to antimicrobial peptides.. Antimicrob. Agents Chemother.
50: 2361-2367
[Abstract]
[Full Text]